Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stomach Neoplasms | 16 | 2024 | 1481 | 1.630 |
Why?
|
Pancreatic Neoplasms | 8 | 2022 | 5446 | 1.420 |
Why?
|
Pancreatectomy | 5 | 2022 | 825 | 1.290 |
Why?
|
Adenocarcinoma | 15 | 2024 | 6360 | 1.180 |
Why?
|
Veterans Health | 3 | 2022 | 216 | 1.020 |
Why?
|
Carcinoid Tumor | 3 | 2012 | 225 | 1.020 |
Why?
|
Pancreaticoduodenectomy | 5 | 2020 | 515 | 0.950 |
Why?
|
Gastrointestinal Stromal Tumors | 5 | 2009 | 616 | 0.800 |
Why?
|
Biliary Tract | 1 | 2019 | 136 | 0.590 |
Why?
|
Bile | 1 | 2019 | 300 | 0.590 |
Why?
|
Nomograms | 2 | 2009 | 236 | 0.540 |
Why?
|
Appendicitis | 1 | 2023 | 679 | 0.530 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2015 | 151 | 0.470 |
Why?
|
Colonic Neoplasms | 3 | 2014 | 2535 | 0.460 |
Why?
|
Neoplasm Staging | 10 | 2016 | 11217 | 0.460 |
Why?
|
Hepatectomy | 3 | 2019 | 589 | 0.460 |
Why?
|
Chemokine CCL20 | 1 | 2014 | 64 | 0.450 |
Why?
|
Receptors, CCR6 | 1 | 2014 | 73 | 0.450 |
Why?
|
Piperazines | 4 | 2009 | 2548 | 0.450 |
Why?
|
Genes, APC | 1 | 2014 | 144 | 0.440 |
Why?
|
Interleukin-17 | 2 | 2015 | 922 | 0.410 |
Why?
|
Esophageal Neoplasms | 5 | 2024 | 1661 | 0.410 |
Why?
|
Lymphatic Metastasis | 8 | 2018 | 2900 | 0.400 |
Why?
|
Pyrimidines | 4 | 2009 | 3044 | 0.400 |
Why?
|
Healthcare Disparities | 3 | 2022 | 3414 | 0.390 |
Why?
|
Esophagogastric Junction | 5 | 2024 | 350 | 0.390 |
Why?
|
Colectomy | 2 | 2020 | 696 | 0.380 |
Why?
|
Colorectal Neoplasms | 7 | 2021 | 6966 | 0.380 |
Why?
|
Intestinal Neoplasms | 1 | 2014 | 314 | 0.380 |
Why?
|
Pancreas | 4 | 2022 | 1699 | 0.380 |
Why?
|
Lymph Node Excision | 4 | 2016 | 1267 | 0.370 |
Why?
|
Survival Rate | 11 | 2021 | 12823 | 0.370 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 594 | 0.370 |
Why?
|
Lymph Nodes | 3 | 2011 | 3468 | 0.370 |
Why?
|
Early Diagnosis | 1 | 2016 | 1188 | 0.360 |
Why?
|
Postoperative Complications | 8 | 2020 | 15824 | 0.360 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2006 | 957 | 0.340 |
Why?
|
Vaccines, DNA | 4 | 2006 | 279 | 0.340 |
Why?
|
Health Status Disparities | 1 | 2021 | 1882 | 0.340 |
Why?
|
Patient Discharge | 5 | 2020 | 3467 | 0.320 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1759 | 0.310 |
Why?
|
Endoscopy, Gastrointestinal | 3 | 2016 | 888 | 0.300 |
Why?
|
Veterans | 1 | 2022 | 2666 | 0.300 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2843 | 0.290 |
Why?
|
Antineoplastic Agents | 7 | 2015 | 13650 | 0.290 |
Why?
|
Incidental Findings | 1 | 2012 | 698 | 0.280 |
Why?
|
Duodenal Neoplasms | 1 | 2007 | 114 | 0.270 |
Why?
|
Bile Ducts | 2 | 2019 | 288 | 0.270 |
Why?
|
Socioeconomic Factors | 4 | 2022 | 7848 | 0.270 |
Why?
|
Melanoma | 7 | 2023 | 5702 | 0.270 |
Why?
|
Prognosis | 16 | 2024 | 29963 | 0.260 |
Why?
|
Antigens, Heterophile | 2 | 2003 | 71 | 0.260 |
Why?
|
Gastrectomy | 6 | 2018 | 693 | 0.250 |
Why?
|
Mediastinal Diseases | 1 | 2006 | 91 | 0.250 |
Why?
|
Digestive System Surgical Procedures | 2 | 2016 | 584 | 0.250 |
Why?
|
Sternum | 1 | 2006 | 177 | 0.250 |
Why?
|
Cholestasis | 2 | 2019 | 385 | 0.240 |
Why?
|
Skilled Nursing Facilities | 2 | 2019 | 405 | 0.240 |
Why?
|
Streptococcus bovis | 1 | 2004 | 4 | 0.240 |
Why?
|
Hyperparathyroidism | 1 | 2006 | 339 | 0.240 |
Why?
|
SEER Program | 3 | 2015 | 1444 | 0.220 |
Why?
|
Insurance, Health | 1 | 2016 | 2519 | 0.220 |
Why?
|
Aged | 37 | 2024 | 171319 | 0.210 |
Why?
|
Protein Kinase Inhibitors | 3 | 2009 | 5693 | 0.210 |
Why?
|
Middle Aged | 40 | 2024 | 223233 | 0.210 |
Why?
|
Humans | 67 | 2024 | 767040 | 0.200 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2007 | 734 | 0.200 |
Why?
|
Melanoma, Experimental | 2 | 2003 | 557 | 0.200 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2018 | 754 | 0.200 |
Why?
|
Cardia | 2 | 2020 | 61 | 0.200 |
Why?
|
Patient Transfer | 2 | 2019 | 788 | 0.190 |
Why?
|
Benzamides | 4 | 2009 | 1376 | 0.190 |
Why?
|
Aged, 80 and over | 20 | 2024 | 59548 | 0.190 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5859 | 0.180 |
Why?
|
Male | 44 | 2024 | 364203 | 0.180 |
Why?
|
Neoadjuvant Therapy | 4 | 2019 | 2902 | 0.180 |
Why?
|
Fibroma | 1 | 2002 | 196 | 0.170 |
Why?
|
Female | 44 | 2024 | 396660 | 0.170 |
Why?
|
Streptococcal Infections | 1 | 2004 | 618 | 0.170 |
Why?
|
Appendectomy | 1 | 2023 | 444 | 0.160 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2003 | 827 | 0.160 |
Why?
|
Cell Proliferation | 5 | 2018 | 10455 | 0.160 |
Why?
|
Cancer Vaccines | 3 | 2003 | 1041 | 0.160 |
Why?
|
Neoplasm Invasiveness | 6 | 2018 | 3611 | 0.160 |
Why?
|
Reoperation | 3 | 2019 | 4325 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 6 | 2024 | 6513 | 0.150 |
Why?
|
Neoplasm Proteins | 3 | 2011 | 3599 | 0.150 |
Why?
|
Retrospective Studies | 17 | 2021 | 81659 | 0.150 |
Why?
|
Thymosin | 1 | 1997 | 47 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 520 | 0.140 |
Why?
|
Patient Selection | 1 | 2009 | 4256 | 0.140 |
Why?
|
Rehabilitation Centers | 1 | 2019 | 249 | 0.140 |
Why?
|
Bacteremia | 1 | 2004 | 983 | 0.140 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6106 | 0.140 |
Why?
|
Heart Neoplasms | 1 | 2020 | 374 | 0.140 |
Why?
|
Hospices | 1 | 2019 | 245 | 0.130 |
Why?
|
Length of Stay | 5 | 2020 | 6489 | 0.130 |
Why?
|
Transcription Factors | 1 | 2015 | 12158 | 0.130 |
Why?
|
Membrane Glycoproteins | 3 | 2003 | 3702 | 0.130 |
Why?
|
Proportional Hazards Models | 7 | 2015 | 12536 | 0.130 |
Why?
|
Cell Movement | 2 | 2018 | 5203 | 0.120 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1104 | 0.120 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 1697 | 0.120 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39317 | 0.120 |
Why?
|
Morbidity | 1 | 2020 | 1754 | 0.120 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 358 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2019 | 3552 | 0.120 |
Why?
|
Digestive System Diseases | 1 | 2016 | 152 | 0.120 |
Why?
|
Choristoma | 1 | 2016 | 205 | 0.120 |
Why?
|
Risk Factors | 14 | 2024 | 74886 | 0.110 |
Why?
|
Carcinoma | 2 | 2015 | 2326 | 0.110 |
Why?
|
Sex Factors | 4 | 2021 | 10622 | 0.110 |
Why?
|
Carcinoma, Lobular | 1 | 1997 | 480 | 0.110 |
Why?
|
Soft Tissue Neoplasms | 1 | 2002 | 1162 | 0.100 |
Why?
|
Neoplastic Stem Cells | 1 | 2021 | 1349 | 0.100 |
Why?
|
Specialties, Surgical | 1 | 2017 | 391 | 0.100 |
Why?
|
Adult | 22 | 2018 | 223317 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7236 | 0.100 |
Why?
|
Cell Adhesion Molecules | 1 | 1998 | 1612 | 0.100 |
Why?
|
Carcinoma in Situ | 1 | 1997 | 784 | 0.100 |
Why?
|
Liver Neoplasms | 1 | 2008 | 4357 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2023 | 65295 | 0.100 |
Why?
|
China | 5 | 2016 | 2394 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2008 | 9410 | 0.090 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1969 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2017 | 744 | 0.090 |
Why?
|
Stomach | 1 | 2015 | 701 | 0.090 |
Why?
|
Time Factors | 8 | 2020 | 40154 | 0.090 |
Why?
|
Peritoneum | 1 | 2012 | 227 | 0.090 |
Why?
|
Stromal Cells | 1 | 2016 | 1335 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 1997 | 1097 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2016 | 15424 | 0.080 |
Why?
|
Survival Analysis | 6 | 2008 | 10092 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2472 | 0.080 |
Why?
|
Phosphoproteins | 1 | 1998 | 2448 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1043 | 0.080 |
Why?
|
Mitotic Index | 1 | 2009 | 160 | 0.080 |
Why?
|
Risk Assessment | 7 | 2019 | 24299 | 0.080 |
Why?
|
Stents | 2 | 2020 | 3193 | 0.080 |
Why?
|
Neoplasm Metastasis | 4 | 2007 | 4892 | 0.080 |
Why?
|
World Health Organization | 1 | 2015 | 1327 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3567 | 0.080 |
Why?
|
Spain | 1 | 2009 | 483 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2021 | 5332 | 0.070 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2011 | 645 | 0.070 |
Why?
|
Telomere | 1 | 2013 | 943 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4572 | 0.070 |
Why?
|
Mice | 11 | 2018 | 81912 | 0.070 |
Why?
|
Dacarbazine | 1 | 2010 | 552 | 0.070 |
Why?
|
Tumor Burden | 1 | 2013 | 1903 | 0.070 |
Why?
|
Blotting, Western | 1 | 2014 | 5022 | 0.070 |
Why?
|
Adolescent | 9 | 2016 | 89046 | 0.070 |
Why?
|
Immunotherapy, Active | 1 | 2006 | 58 | 0.070 |
Why?
|
gp100 Melanoma Antigen | 2 | 2003 | 37 | 0.070 |
Why?
|
Mice, Inbred C57BL | 7 | 2014 | 22361 | 0.060 |
Why?
|
Fluorouracil | 1 | 2011 | 1652 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2008 | 723 | 0.060 |
Why?
|
Disease-Free Survival | 3 | 2009 | 6844 | 0.060 |
Why?
|
Metaplasia | 2 | 2020 | 326 | 0.060 |
Why?
|
Young Adult | 5 | 2016 | 59980 | 0.060 |
Why?
|
Esophagus | 1 | 2011 | 1041 | 0.060 |
Why?
|
Endoscopy | 2 | 2015 | 1854 | 0.060 |
Why?
|
Databases as Topic | 1 | 2007 | 472 | 0.060 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8535 | 0.060 |
Why?
|
Autoantigens | 2 | 2006 | 890 | 0.060 |
Why?
|
United States | 6 | 2019 | 72971 | 0.060 |
Why?
|
Age Factors | 3 | 2020 | 18401 | 0.060 |
Why?
|
Incidence | 3 | 2018 | 21526 | 0.060 |
Why?
|
Animals | 13 | 2021 | 168965 | 0.050 |
Why?
|
Asparagine | 1 | 2003 | 120 | 0.050 |
Why?
|
Massachusetts | 1 | 2016 | 8890 | 0.050 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2003 | 361 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2006 | 4405 | 0.050 |
Why?
|
H-2 Antigens | 1 | 2003 | 359 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2003 | 411 | 0.050 |
Why?
|
Databases, Factual | 4 | 2020 | 8068 | 0.050 |
Why?
|
Apoptosis | 2 | 2018 | 9513 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2003 | 1352 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8628 | 0.050 |
Why?
|
Tibial Nerve | 1 | 2002 | 55 | 0.050 |
Why?
|
Comorbidity | 3 | 2020 | 10582 | 0.050 |
Why?
|
Peroneal Nerve | 1 | 2002 | 80 | 0.050 |
Why?
|
Prospective Studies | 5 | 2018 | 54886 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3431 | 0.050 |
Why?
|
Genes, Neoplasm | 1 | 2003 | 369 | 0.050 |
Why?
|
Adjuvants, Immunologic | 1 | 2006 | 998 | 0.050 |
Why?
|
Neoplasms | 3 | 2006 | 22350 | 0.050 |
Why?
|
Tryptophan | 1 | 2003 | 484 | 0.050 |
Why?
|
Denervation | 1 | 2002 | 265 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 1837 | 0.040 |
Why?
|
Patient Readmission | 3 | 2020 | 3283 | 0.040 |
Why?
|
Neoplasms, Experimental | 1 | 2006 | 1228 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2018 | 3608 | 0.040 |
Why?
|
Ostomy | 1 | 2020 | 33 | 0.040 |
Why?
|
Barrett Esophagus | 1 | 2024 | 494 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20741 | 0.040 |
Why?
|
Age Distribution | 2 | 2016 | 2870 | 0.040 |
Why?
|
Quality Improvement | 3 | 2020 | 3854 | 0.040 |
Why?
|
Child | 4 | 2011 | 80771 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 12793 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 17097 | 0.040 |
Why?
|
Catenins | 1 | 1998 | 44 | 0.040 |
Why?
|
Limb Salvage | 1 | 2002 | 488 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2014 | 14476 | 0.040 |
Why?
|
Amino Acid Substitution | 1 | 2003 | 1743 | 0.040 |
Why?
|
Oximes | 1 | 2020 | 305 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9245 | 0.040 |
Why?
|
Sciatic Nerve | 1 | 2002 | 627 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2015 | 11657 | 0.040 |
Why?
|
Rhabdomyosarcoma | 1 | 2001 | 358 | 0.040 |
Why?
|
Autoimmunity | 1 | 2006 | 1361 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11063 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14766 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2020 | 385 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2015 | 5186 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2006 | 13411 | 0.040 |
Why?
|
Ureter | 1 | 2020 | 364 | 0.040 |
Why?
|
Helicobacter pylori | 1 | 2020 | 380 | 0.030 |
Why?
|
Fluorescein | 1 | 2017 | 176 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2006 | 2428 | 0.030 |
Why?
|
Helicobacter Infections | 1 | 2020 | 390 | 0.030 |
Why?
|
Uveal Neoplasms | 1 | 2020 | 344 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2002 | 1012 | 0.030 |
Why?
|
Colonoscopy | 1 | 2004 | 1409 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 6975 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2006 | 4648 | 0.030 |
Why?
|
Health Status | 2 | 2019 | 4091 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2003 | 2217 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 2016 | 521 | 0.030 |
Why?
|
Bilirubin | 1 | 2017 | 440 | 0.030 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 1364 | 0.030 |
Why?
|
Gastroscopy | 1 | 2016 | 213 | 0.030 |
Why?
|
Antigens, Neoplasm | 4 | 2006 | 1997 | 0.030 |
Why?
|
Syndecan-1 | 1 | 2015 | 163 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12069 | 0.030 |
Why?
|
Pyridones | 1 | 2020 | 819 | 0.030 |
Why?
|
Breast Diseases | 1 | 1997 | 441 | 0.030 |
Why?
|
Biopsy | 2 | 2016 | 6777 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 17608 | 0.030 |
Why?
|
North America | 1 | 2018 | 1287 | 0.030 |
Why?
|
Imidazoles | 1 | 2020 | 1169 | 0.030 |
Why?
|
Intramolecular Oxidoreductases | 2 | 2006 | 105 | 0.030 |
Why?
|
Serum Albumin | 1 | 2017 | 676 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2058 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2000 | 1801 | 0.030 |
Why?
|
Registries | 1 | 2009 | 8351 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2322 | 0.030 |
Why?
|
Models, Statistical | 1 | 2007 | 5098 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1337 | 0.030 |
Why?
|
Logistic Models | 2 | 2019 | 13284 | 0.030 |
Why?
|
Osteoclasts | 1 | 2015 | 713 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1443 | 0.020 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2011 | 89 | 0.020 |
Why?
|
Cytokines | 1 | 2006 | 7446 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20169 | 0.020 |
Why?
|
Recovery of Function | 2 | 2017 | 2978 | 0.020 |
Why?
|
Sex Distribution | 1 | 2016 | 2276 | 0.020 |
Why?
|
Protein Binding | 1 | 2003 | 9327 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11872 | 0.020 |
Why?
|
Sarcoma | 1 | 2002 | 1802 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1641 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2003 | 5141 | 0.020 |
Why?
|
Thromboembolism | 1 | 2017 | 1003 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1308 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 1997 | 21178 | 0.020 |
Why?
|
Forecasting | 1 | 2018 | 2936 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2017 | 1928 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2824 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2538 | 0.020 |
Why?
|
Genomic Instability | 1 | 2013 | 716 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2010 | 207 | 0.020 |
Why?
|
Postoperative Care | 1 | 2015 | 1480 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1278 | 0.020 |
Why?
|
Breast | 1 | 1997 | 1972 | 0.020 |
Why?
|
Up-Regulation | 1 | 1997 | 4143 | 0.020 |
Why?
|
Telomerase | 1 | 2013 | 751 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2010 | 342 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1804 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2002 | 892 | 0.020 |
Why?
|
Acute-Phase Reaction | 1 | 2006 | 91 | 0.020 |
Why?
|
Hypopigmentation | 1 | 2006 | 43 | 0.020 |
Why?
|
Mice, SCID | 1 | 2011 | 2626 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2008 | 367 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2015 | 3227 | 0.020 |
Why?
|
Self Tolerance | 1 | 2006 | 122 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4745 | 0.010 |
Why?
|
Genomics | 1 | 2021 | 5924 | 0.010 |
Why?
|
Mutation | 2 | 2008 | 30211 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2006 | 287 | 0.010 |
Why?
|
Disease Models, Animal | 3 | 2015 | 18330 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2004 | 26396 | 0.010 |
Why?
|
COS Cells | 1 | 2006 | 1135 | 0.010 |
Why?
|
Interleukin-12 | 1 | 2006 | 577 | 0.010 |
Why?
|
Cross Reactions | 1 | 2006 | 828 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2006 | 6507 | 0.010 |
Why?
|
Gene Library | 1 | 2006 | 1065 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10393 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2006 | 1989 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2017 | 14672 | 0.010 |
Why?
|
Infant | 1 | 2004 | 36485 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2011 | 3427 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3236 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2003 | 915 | 0.010 |
Why?
|
Child, Preschool | 1 | 2004 | 42606 | 0.010 |
Why?
|
Plasmids | 1 | 2006 | 2268 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12986 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22254 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2015 | 4546 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2800 | 0.010 |
Why?
|
Vaccination | 2 | 2003 | 3434 | 0.010 |
Why?
|
Toll-Like Receptors | 1 | 2003 | 582 | 0.010 |
Why?
|
Toll-Like Receptor 4 | 1 | 2003 | 588 | 0.010 |
Why?
|
Self-Assessment | 1 | 2002 | 400 | 0.010 |
Why?
|
Lung Neoplasms | 2 | 2002 | 13491 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5796 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2001 | 920 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2002 | 2012 | 0.010 |
Why?
|
Transfection | 1 | 2006 | 5753 | 0.010 |
Why?
|
Immunization | 1 | 2002 | 1218 | 0.010 |
Why?
|
Major Histocompatibility Complex | 1 | 2000 | 879 | 0.010 |
Why?
|
Diet | 1 | 2015 | 8089 | 0.010 |
Why?
|
Leg | 1 | 2002 | 1087 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2002 | 1741 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2000 | 2176 | 0.010 |
Why?
|
Antibody Formation | 1 | 2000 | 1392 | 0.010 |
Why?
|
DNA Methylation | 1 | 2010 | 4426 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12414 | 0.010 |
Why?
|
Testicular Neoplasms | 1 | 2001 | 806 | 0.010 |
Why?
|
Spleen | 1 | 2000 | 2292 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 6226 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2003 | 2815 | 0.010 |
Why?
|
Graft Rejection | 1 | 2006 | 4498 | 0.010 |
Why?
|
Cell Division | 1 | 2000 | 4473 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2003 | 2745 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2000 | 3402 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2006 | 10254 | 0.000 |
Why?
|
Quality of Life | 1 | 2002 | 13485 | 0.000 |
Why?
|